On December 9, 2025, Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, will hold a live webinar on December 10, 2025, at 8:30 AM Eastern Time. The company, listed on TSX as MDNA and OTCQX as MDNAF, focuses on developing Superkines for treating cancer, autoimmune, and inflammatory conditions. The webinar will be hosted simultaneously in Toronto and Houston.